|
1A9
|
ED50 |
|
In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line
In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line
|
[PMID: 10612592]
|
|
769-P
|
IC50 |
|
Cytotoxicity against human renal carcinoma 769-P cells assessed as reduction in optical density by MTT assay
Cytotoxicity against human renal carcinoma 769-P cells assessed as reduction in optical density by MTT assay
|
[PMID: 23279863]
|
|
A-375
|
IC50 |
|
Cytotoxicity against human malignant melanoma A375 cells assessed as reduction in optical density by MTT assay
Cytotoxicity against human malignant melanoma A375 cells assessed as reduction in optical density by MTT assay
|
[PMID: 23279863]
|
|
A549
|
ED50 |
|
In vitro cytotoxic activity was determined against lung carcinoma (A549) cell line
In vitro cytotoxic activity was determined against lung carcinoma (A549) cell line
|
[PMID: 10612592]
|
|
A549
|
IC50 |
17.12 μM
Compound: Harmine
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 34425477]
|
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 38154256]
|
|
A549
|
IC50 |
42.25 μM
Compound: Harmine
|
Cytotoxicity against human A549 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 27397495]
|
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
|
[PMID: 35341920]
|
|
A549
|
IC50 |
5.89 μM
Compound: Harmine
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by SRB assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by SRB assay
|
[PMID: 31227365]
|
|
A549
|
IC50 |
52.56 μM
Compound: 6; Harmine
|
Antiproliferative activity against human A549 cells after 24 hrs by MTT assay
Antiproliferative activity against human A549 cells after 24 hrs by MTT assay
|
10.1039/C5MD00581G
|
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 29129513]
|
|
A549
|
IC50 |
> 20 μM
Compound: Harmine
|
Antiproliferative activity against human A549 cells
Antiproliferative activity against human A549 cells
|
[PMID: 37875056]
|
|
BGC-823
|
IC50 |
|
Antiproliferative activity against human BGC-823 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human BGC-823 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
|
[PMID: 35341920]
|
|
BGC-823
|
IC50 |
|
Cytotoxicity against human gastric carcinoma BGC823 cells assessed as reduction in optical density by MTT assay
Cytotoxicity against human gastric carcinoma BGC823 cells assessed as reduction in optical density by MTT assay
|
[PMID: 23279863]
|
|
BGC-823
|
IC50 |
|
Cytotoxicity against human BGC823 cells by MTT assay
Cytotoxicity against human BGC823 cells by MTT assay
|
[PMID: 23291116]
|
|
BGC-823
|
IC50 |
|
Cytotoxicity against human BGC823 cells by MTT assay
Cytotoxicity against human BGC823 cells by MTT assay
|
[PMID: 18462839]
|
|
Bel-7402
|
IC50 |
|
Cytotoxicity against human Bel7402 cells by MTT assay
Cytotoxicity against human Bel7402 cells by MTT assay
|
[PMID: 23291116]
|
|
Bel-7402
|
IC50 |
|
Cytotoxicity against human Bel7402 cells by MTT assay
Cytotoxicity against human Bel7402 cells by MTT assay
|
[PMID: 18462839]
|
|
CAKI-1
|
ED50 |
|
In vitro cytotoxic activity was determined against renal cancer (CAKI-1) cell line
In vitro cytotoxic activity was determined against renal cancer (CAKI-1) cell line
|
[PMID: 10612592]
|
|
COLO 205
|
IC50 |
|
Antiproliferative activity against human COLO205 cells after 24 hrs by MTT assay
Antiproliferative activity against human COLO205 cells after 24 hrs by MTT assay
|
[PMID: 22365759]
|
|
COLO 205
|
IC50 |
|
Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
|
[PMID: 22202437]
|
|
COLO 205
|
IC50 |
|
Antiproliferative activity against human COLO205 cells by MTT assay
Antiproliferative activity against human COLO205 cells by MTT assay
|
[PMID: 22749421]
|
|
COLO 205
|
IC50 |
|
Cytotoxicity against human COLO205 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human COLO205 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 28216402]
|
|
DU-145
|
IC50 |
|
Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
|
[PMID: 29129513]
|
|
DU-145
|
IC50 |
9.63 μM
Compound: Harmine
|
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 48 hrs by SRB assay
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 48 hrs by SRB assay
|
[PMID: 31227365]
|
|
FM3A
|
EC50 |
1.8 x 10 -5 M
Compound: 1i, harmine
|
In vitro cytotoxic activity tested in mouse mammary tumor FM3A cells
In vitro cytotoxic activity tested in mouse mammary tumor FM3A cells
|
[PMID: 15026051]
|
|
H9
|
EC50 |
|
Antiviral activity against HIV1 in human H9 cells assessed as inhibition of viral replication
Antiviral activity against HIV1 in human H9 cells assessed as inhibition of viral replication
|
[PMID: 11473435]
|
|
H9
|
IC50 |
|
Cytotoxicity against human H9 cells
Cytotoxicity against human H9 cells
|
[PMID: 11473435]
|
|
HCT-116
|
IC50 |
43.8 μM
Compound: Harmine
|
Antiproliferative activity against human HCT116 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells incubated for 48 hrs by MTT assay
|
[PMID: 30851694]
|
|
HCT-116
|
IC50 |
43.8 μM
Compound: Harmine
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 35272009]
|
|
HCT-116
|
IC50 |
46.7 μM
Compound: Harmine
|
Antiproliferative activity against human HCT116 cells assessed as cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 26555243]
|
|
HCT-116
|
IC50 |
46.7 μM
Compound: Harmine
|
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 29288941]
|
|
HCT-116
|
IC50 |
46.7 μM
Compound: Harmine
|
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 30108831]
|
|
HCT-116
|
IC50 |
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
|
[PMID: 35341920]
|
|
HCT-116
|
IC50 |
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38677112]
|
|
HCT-116
|
IC50 |
> 20 μM
Compound: Harmine
|
Antiproliferative activity against human HCT-116 cells
Antiproliferative activity against human HCT-116 cells
|
[PMID: 37875056]
|
|
HEK-293T
|
IC50 |
|
Antiproliferative activity against human HEK293T cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human HEK293T cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38677112]
|
|
HEK293
|
IC50 |
|
Inhibition of tetracycline-inducible EGFP-DYRK1A (unknown origin) expressed in HEK293 cells coexpressing full length human EGFP-tau protein assessed as reduction in tau-Thr212 phosphorylation incubated overnight by immunofluorescence assay
Inhibition of tetracycline-inducible EGFP-DYRK1A (unknown origin) expressed in HEK293 cells coexpressing full length human EGFP-tau protein assessed as reduction in tau-Thr212 phosphorylation incubated overnight by immunofluorescence assay
|
[PMID: 26896709]
|
|
HEL
|
ED50 |
|
In vitro cytotoxic activity was determined against embryonic lung fibroblast (HEL) cell line
In vitro cytotoxic activity was determined against embryonic lung fibroblast (HEL) cell line
|
[PMID: 10612592]
|
|
HGC-27
|
IC50 |
3.52 μM
Compound: Harmine
|
Antiproliferative activity against human HGC27 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HGC27 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197]
|
|
HL-60
|
IC50 |
62.45 μM
Compound: 6; Harmine
|
Antiproliferative activity against human HL60 cells after 24 hrs by MTT assay
Antiproliferative activity against human HL60 cells after 24 hrs by MTT assay
|
10.1039/C5MD00581G
|
|
HL-60
|
IC50 |
|
Antiproliferative activity against human HL60 cells by tryphan blue assay
Antiproliferative activity against human HL60 cells by tryphan blue assay
|
[PMID: 28128938]
|
|
HT-22
|
IC50 |
|
Cytotoxicity against mouse HT-22 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Cytotoxicity against mouse HT-22 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 36876904]
|
|
HT-29
|
IC50 |
|
Antiproliferative activity against human HT-29 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 38154256]
|
|
HT-29
|
IC50 |
3.52 μM
Compound: Harmine
|
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197]
|
|
HT-29
|
IC50 |
41.8 μM
Compound: Harmine
|
Antiproliferative activity against human HT-29 cells by MTT assay
Antiproliferative activity against human HT-29 cells by MTT assay
|
[PMID: 32787089]
|
|
HT-29
|
IC50 |
> 20 μM
Compound: Harmine
|
Antiproliferative activity against human HT-29 cells
Antiproliferative activity against human HT-29 cells
|
[PMID: 37875056]
|
|
HeLa
|
IC50 |
|
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 29129513]
|
|
HeLa
|
IC50 |
|
Cytotoxicity against human HeLa cells by MTT assay
Cytotoxicity against human HeLa cells by MTT assay
|
[PMID: 23291116]
|
|
HeLa
|
IC50 |
|
Cytotoxicity against human HeLa cells by MTT assay
Cytotoxicity against human HeLa cells by MTT assay
|
[PMID: 18462839]
|
|
HeLa
|
IC50 |
|
Cytotoxicity against human HeLa cells after 5 days by MTT assay
Cytotoxicity against human HeLa cells after 5 days by MTT assay
|
[PMID: 30193214]
|
|
HeLa
|
IC50 |
85.28 μM
Compound: 6; Harmine
|
Antiproliferative activity against human HeLa cells after 24 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 24 hrs by MTT assay
|
10.1039/C5MD00581G
|
|
HeLa
|
IC50 |
9.66 μM
Compound: Harmine
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by SRB assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by SRB assay
|
[PMID: 31227365]
|
|
HeLa
|
IC50 |
> 10 μM
Compound: Harmine
|
Inhibition of HDAC in human HeLa cell nuclear extract using Boc-Lys (Ac)-AMC as substrate after 60 mins by fluorometric analysis
Inhibition of HDAC in human HeLa cell nuclear extract using Boc-Lys (Ac)-AMC as substrate after 60 mins by fluorometric analysis
|
[PMID: 26555243]
|
|
HeLa
|
IC50 |
> 10 μM
Compound: Harmine
|
Inhibition of HDAC in human HeLa nuclear extract
Inhibition of HDAC in human HeLa nuclear extract
|
[PMID: 30245394]
|
|
HepG2
|
IC50 |
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38677112]
|
|
HepG2
|
IC50 |
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
|
[PMID: 35341920]
|
|
HepG2
|
IC50 |
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 38154256]
|
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 23291116]
|
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 18462839]
|
|
HepG2
|
IC50 |
49.96 μM
Compound: Harmine
|
Antiproliferative activity against human HepG2 cells by MTT assay
Antiproliferative activity against human HepG2 cells by MTT assay
|
[PMID: 32787089]
|
|
HepG2
|
IC50 |
51.2 μM
Compound: Harmine
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 29288941]
|
|
HepG2
|
IC50 |
51.2 μM
Compound: Harmine
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 30108831]
|
|
HepG2
|
IC50 |
53.6 μM
Compound: Harmine
|
Antiproliferative activity against human HepG2 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells incubated for 48 hrs by MTT assay
|
[PMID: 30851694]
|
|
HepG2
|
IC50 |
53.6 μM
Compound: Harmine
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 31120744]
|
|
HepG2
|
IC50 |
> 20 μM
Compound: Harmine
|
Antiproliferative activity against human HepG2 cells
Antiproliferative activity against human HepG2 cells
|
[PMID: 37875056]
|
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition incubated for 1 day by neutral red assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition incubated for 1 day by neutral red assay
|
[PMID: 34274829]
|
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition incubated for 1 day by neutral red assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition incubated for 1 day by neutral red assay
|
[PMID: 35551033]
|
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 37696205]
|
|
HepG2
|
IC50 |
> 250 μM
Compound: Harmine
|
Cytotoxicity against human HepG2 cells measured after 24 hrs by neutral red assay
Cytotoxicity against human HepG2 cells measured after 24 hrs by neutral red assay
|
[PMID: 31812035]
|
|
Hs 683
|
IC50 |
|
Growth inhibition of human Hs 683 cells after 3 days by MTT assay
Growth inhibition of human Hs 683 cells after 3 days by MTT assay
|
[PMID: 22770529]
|
|
Hs 683
|
IC50 |
37 μM
Compound: 1, Harmine
|
Cytostatic activity against human Hs683 cells after 72 hrs by videomicroscopy
Cytostatic activity against human Hs683 cells after 72 hrs by videomicroscopy
|
[PMID: 25747498]
|
|
IMR-32
|
IC50 |
|
Antiproliferative activity against human IMR32 cells after 24 hrs by MTT assay
Antiproliferative activity against human IMR32 cells after 24 hrs by MTT assay
|
[PMID: 22365759]
|
|
IMR-32
|
IC50 |
|
Cytotoxicity against human IMR32 cells after 24 hrs by MTT assay
Cytotoxicity against human IMR32 cells after 24 hrs by MTT assay
|
[PMID: 22202437]
|
|
K562
|
IC50 |
|
Antiproliferative activity against human K562 cells by MTT assay
Antiproliferative activity against human K562 cells by MTT assay
|
[PMID: 22749421]
|
|
K562
|
IC50 |
|
Cytotoxicity against human K562 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human K562 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 28216402]
|
|
K562
|
IC50 |
|
Antiproliferative activity against human K562 cells after 24 hrs by MTT assay
Antiproliferative activity against human K562 cells after 24 hrs by MTT assay
|
[PMID: 22365759]
|
|
K562
|
IC50 |
|
Cytotoxicity against human K562 cells after 24 hrs by MTT assay
Cytotoxicity against human K562 cells after 24 hrs by MTT assay
|
[PMID: 22202437]
|
|
K562
|
IC50 |
|
Antiproliferative activity against human K562 cells assessed as cell growth inhibition after 24 hrs by MTT assay
Antiproliferative activity against human K562 cells assessed as cell growth inhibition after 24 hrs by MTT assay
|
[PMID: 22516283]
|
|
KB
|
ED50 |
|
In vitro cytotoxic activity was determined against epidermoid carcinoma of the nasopharynx (KB) cell line
In vitro cytotoxic activity was determined against epidermoid carcinoma of the nasopharynx (KB) cell line
|
[PMID: 10612592]
|
|
KB
|
ED50 |
|
In vitro cytotoxic activity was determined against drug resistant tumor cell line KB-VIN (expressing P-glycoprotein)
In vitro cytotoxic activity was determined against drug resistant tumor cell line KB-VIN (expressing P-glycoprotein)
|
[PMID: 10612592]
|
|
KB
|
ED50 |
|
In vitro cytotoxic activity was determined against drug resistant tumor cell line KB-7d (pleotrophic resistance including MRP multidrug resistant protein)
In vitro cytotoxic activity was determined against drug resistant tumor cell line KB-7d (pleotrophic resistance including MRP multidrug resistant protein)
|
[PMID: 10612592]
|
|
KB
|
ED50 |
|
In vitro cytotoxic activity was determined against drug resistant tumor cell line KB-CPT (pleotrophic mechanism including level of topoisomerase I)
In vitro cytotoxic activity was determined against drug resistant tumor cell line KB-CPT (pleotrophic mechanism including level of topoisomerase I)
|
[PMID: 10612592]
|
|
KB
|
IC50 |
|
Cytotoxicity against human epidermoid carcinoma of the nasopharynx KB cells assessed as reduction in optical density by MTT assay
Cytotoxicity against human epidermoid carcinoma of the nasopharynx KB cells assessed as reduction in optical density by MTT assay
|
[PMID: 23279863]
|
|
L02
|
IC50 |
|
Cytotoxicity against human L02 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
Cytotoxicity against human L02 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
|
[PMID: 35341920]
|
|
L02
|
IC50 |
|
Cytotoxicity against human L02 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human L02 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 38154256]
|
|
LoVo
|
IC50 |
53.2 μM
Compound: Harmine
|
Antiproliferative activity against human LoVo cells assessed as cell viability after 48 hrs by MTT assay
Antiproliferative activity against human LoVo cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 26555243]
|
|
LoVo
|
IC50 |
53.2 μM
Compound: Harmine
|
Antiproliferative activity against human LoVo cells after 48 hrs by MTT assay
Antiproliferative activity against human LoVo cells after 48 hrs by MTT assay
|
[PMID: 30108831]
|
|
MCF7
|
ED50 |
|
In vitro cytotoxic activity against MCF-7 (human breast cancer) cell line.
In vitro cytotoxic activity against MCF-7 (human breast cancer) cell line.
|
[PMID: 10612592]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 29129513]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 38154256]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38677112]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
|
[PMID: 35341920]
|
|
MCF7
|
IC50 |
16.94 μM
Compound: Harmine
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
|
[PMID: 33744443]
|
|
MCF7
|
IC50 |
3.52 μM
Compound: Harmine
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31546197]
|
|
MCF7
|
IC50 |
68.33 μM
Compound: Harmine
|
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 27397495]
|
|
MCF7
|
IC50 |
70.7 μM
Compound: 6; Harmine
|
Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay
|
10.1039/C5MD00581G
|
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells by MTT assay
Cytotoxicity against human MCF7 cells by MTT assay
|
[PMID: 18462839]
|
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 38154256]
|
|
MDA-MB-231
|
IC50 |
21.91 μM
Compound: Harmine
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by CCK-8 assay
|
[PMID: 33744443]
|
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells by MTT assay
Antiproliferative activity against human MDA-MB-231 cells by MTT assay
|
[PMID: 22749421]
|
|
MDA-MB-231
|
IC50 |
|
Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 28216402]
|
|
MDA-MB-231
|
IC50 |
|
Cytotoxicity against human MDA-MB-231 cells after 24 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells after 24 hrs by MTT assay
|
[PMID: 22202437]
|
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition after 24 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition after 24 hrs by MTT assay
|
[PMID: 22516283]
|
|
MDA-MB-435
|
IC50 |
17.1 μM
Compound: Harmine
|
Antiproliferative activity against human MDA-MB-435 cells assessed as inhibition of cell growth incubated for 5 days by MTT assay
Antiproliferative activity against human MDA-MB-435 cells assessed as inhibition of cell growth incubated for 5 days by MTT assay
|
[PMID: 33813152]
|
|
MDA-MB-435
|
IC50 |
> 100 μM
Compound: Harmine
|
Cytotoxicity against human MDA-MB-435 cells assessed as reduction in cell viability incubated for 1 day by MTT assay
Cytotoxicity against human MDA-MB-435 cells assessed as reduction in cell viability incubated for 1 day by MTT assay
|
[PMID: 33813152]
|
|
MDCK-II
|
GI50 |
|
Cytotoxicity against wild-type MDCK2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against wild-type MDCK2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 27280693]
|
|
MDCK-II
|
GI50 |
2.42 μM
Compound: Harmine
|
Cytotoxicity against MDCK2 cells expressing human ABCG2 assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against MDCK2 cells expressing human ABCG2 assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 27280693]
|
|
NCI-H2228
|
IC50 |
31.06 μM
Compound: Harmine
|
Antiproliferative activity against human EML4-ALK positive H2228 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human EML4-ALK positive H2228 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 34425477]
|
|
OE33
|
IC50 |
|
Growth inhibition of human OE33 cells after 3 days by MTT assay
Growth inhibition of human OE33 cells after 3 days by MTT assay
|
[PMID: 22770529]
|
|
PC-3
|
IC50 |
|
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 38154256]
|
|
PC-3
|
IC50 |
3.52 μM
Compound: Harmine
|
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197]
|
|
Pancreatic beta cell
|
EC50 |
7.48 μM
Compound: Telepathine
|
Induction of cell proliferation in rat beta cells
Induction of cell proliferation in rat beta cells
|
[PMID: 32077280]
|
|
Platelet
|
IC50 |
|
Antiplatelet activity in rabbit platelets assessed as inhibition of collagen-induced platelet aggregation
Antiplatelet activity in rabbit platelets assessed as inhibition of collagen-induced platelet aggregation
|
[PMID: 21983333]
|
|
Platelet
|
IC50 |
> 130 μM
Compound: Harmine
|
Antiplatelet aggregation activity against collagen-induced platelet
Antiplatelet aggregation activity against collagen-induced platelet
|
[PMID: 20329729]
|
|
SGC-7901
|
IC50 |
40.82 μM
Compound: Harmine
|
Cytotoxicity against human SGC7901 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Cytotoxicity against human SGC7901 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 27397495]
|
|
SGC-7901
|
IC50 |
70.36 μM
Compound: 6; Harmine
|
Antiproliferative activity against human SGC7901 cells after 24 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells after 24 hrs by MTT assay
|
10.1039/C5MD00581G
|
|
SK-MEL-2
|
ED50 |
|
In vitro cytotoxic activity was determined against melanoma cancer (SK-MEL-2) cell line
In vitro cytotoxic activity was determined against melanoma cancer (SK-MEL-2) cell line
|
[PMID: 10612592]
|
|
SK-OV-3
|
IC50 |
|
Cytotoxicity against human ovary adenocarcinoma SKOV3 cells assessed as reduction in optical density by MTT assay
Cytotoxicity against human ovary adenocarcinoma SKOV3 cells assessed as reduction in optical density by MTT assay
|
[PMID: 23279863]
|
|
SMMC-7721
|
IC50 |
47.6 μM
Compound: Harmine
|
Antiproliferative activity against human SMMC7721 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human SMMC7721 cells incubated for 48 hrs by MTT assay
|
[PMID: 30851694]
|
|
SMMC-7721
|
IC50 |
47.6 μM
Compound: Harmine
|
Antiproliferative activity against human SMMC7721 cells after 72 hrs by MTT assay
Antiproliferative activity against human SMMC7721 cells after 72 hrs by MTT assay
|
[PMID: 31120744]
|
|
SMMC-7721
|
IC50 |
55.3 μM
Compound: Harmine
|
Antiproliferative activity against human SMMC7721 cells after 48 hrs by MTT assay
Antiproliferative activity against human SMMC7721 cells after 48 hrs by MTT assay
|
[PMID: 29288941]
|
|
SMMC-7721
|
IC50 |
55.3 μM
Compound: Harmine
|
Antiproliferative activity against human SMMC7721 cells after 48 hrs by MTT assay
Antiproliferative activity against human SMMC7721 cells after 48 hrs by MTT assay
|
[PMID: 30108831]
|
|
SMMC-7721
|
IC50 |
59.44 μM
Compound: Harmine
|
Cytotoxicity against human SMMC7721 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 27397495]
|
|
SW-620
|
IC50 |
42.8 μM
Compound: Harmine
|
Antiproliferative activity against human SW620 cells assessed as cell viability after 48 hrs by MTT assay
Antiproliferative activity against human SW620 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 26555243]
|
|
SW-620
|
IC50 |
|
Antiproliferative activity against human SW620 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38677112]
|
|
T98G
|
IC50 |
|
Growth inhibition of human T98G cells after 3 days by MTT assay
Growth inhibition of human T98G cells after 3 days by MTT assay
|
[PMID: 22770529]
|
|
U-373MG ATCC
|
IC50 |
|
Growth inhibition of human U373 cells after 3 days by MTT assay
Growth inhibition of human U373 cells after 3 days by MTT assay
|
[PMID: 22770529]
|
|
U-87MG ATCC
|
ED50 |
|
In vitro cytotoxic activity against U-87-MG (glioblastoma) cell line.
In vitro cytotoxic activity against U-87-MG (glioblastoma) cell line.
|
[PMID: 10612592]
|
|
U-87MG ATCC
|
IC50 |
|
Growth inhibition of human U87MG cells after 4 days by MTT assay
Growth inhibition of human U87MG cells after 4 days by MTT assay
|
[PMID: 26896709]
|